On the other hand, 70–100% of patients receiving radiation therapy following BC experienced radiation-induced skin toxicity [88] comparable to UV exposure, which was associated with decreased postmenopausal BCR, due to higher circulating concentration of a precursor to the active form of vitamin D [89]. The gene discussed is BCR; the disease is breast cancer.